SCHEMBL2807892

SCHEMBL2807892

C=CCCCC(CCC=O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
ABCC4 O15439 1/20 0.39
FOLH1 Q04609 6/20 0.36
CHRM1 P11229 1/20 0.35
AKR1A1 P14550 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
HRH1 P35367 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CA2 P00918 1/20 0.35
MAPK1 P28482 1/20 0.35
GRIK1 P39086 2/20 0.35
GRIK2 Q13002 2/20 0.35
TBXAS1 P24557 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5494036 0.90 ABCC4 (0.43) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL3779386 0.90 ABCC4 (0.46) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL5975672 0.86 MAPT (0.48) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL4016679 0.84 MAPT (0.50) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL7003560 0.82 ABCC4 (0.41) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL21439803 0.82 MAPT (0.54) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL4015850 0.82 MAPT (0.54) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL3804921 0.82 MAPT (0.54) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL3103111 0.82 MAPT (0.54) MAPTABCC4FOLH1CHRM1AKR1A1
SCHEMBL10893905 0.82 MAPT (0.54) MAPTABCC4FOLH1CHRM1AKR1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240896-A1 METHOD FOR HYDROFORMYLATION BASF SE (DE) 2010-09-23 US disclosed
EP-2207783-A1 METHOD FOR HYDROFORMYLATION BASF SE (DE) 2010-07-21 EP disclosed
WO-2009059963-A1 METHOD FOR HYDROFORMYLATION BASF SE (DE) 2009-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240896-A1 METHOD FOR HYDROFORMYLATION CBR3, GRHPR, PRDX2 MAPT 4883/4885ABCC4 1746/4885FOLH1 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.